Antiproliferative effect of exemestane in lung cancer cells

Antiproliferative effect of exemestane in lung cancer cells

<p>Abstract</p> <p>Background</p> <p>Recent evidence suggests that estrogen signaling may be involved in the pathogenesis of non-small cell lung cancer (NSCLC). Aromatase is an enzyme complex that catalyses the final step in estrogen synthesis and is present in several...

Full description

Bibliographic Details
Main Authors:	Giannopoulou Efstathia, Kritikou Ismini, Antonacopoulou Anna, Papavassiliou Athanasios, Evans TR Jeffry, Koutras Angelos, Kalofonos Haralabos
Format:	Article
Language:	English
Published:	BMC 2009-01-01
Series:	Molecular Cancer
Online Access:	http://www.molecular-cancer.com/content/8/1/109

Similar Items

The Exposure of Breast Cancer Cells to Fulvestrant and Tamoxifen Modulates Cell Migration Differently
by: Dionysia Lymperatou, et al.
Published: (2013-01-01)

Exemestane in the prevention setting
by: Jennifer Keating Litton, et al.
Published: (2012-05-01)

Exemestane: A milestone against breast cancer
by: Shetty Y, et al.
Published: (2007-01-01)

Exemestane in early breast cancer: a review
by: Michael Untch, et al.
Published: (2008-12-01)

Expression of Immune System-Related Membrane Receptors CD40, RANK, BAFFR and LTβR is Associated with Clinical Outcome of Operated Non-Small-Cell Lung Cancer Patients
by: Foteinos-Ioannis D. Dimitrakopoulos, et al.
Published: (2019-05-01)

NF-κB2 and RELB offer prognostic information in colorectal cancer and NFKB2 rs7897947 represents a genetic risk factor for disease development
by: Anna Antonacopoulou, et al.
Published: (2021-01-01)

Apoptosis and autophagy in breast cancer cells following exemestane treatment.
by: Cristina Amaral, et al.
Published: (2012-01-01)

Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal Women
by: Muaiad Kittaneh, et al.
Published: (2011-10-01)

Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal Women
by: Muaiad Kittaneh, et al.
Published: (2011-01-01)

A review of the use of exemestane in early breast cancer
by: Andrew Robinson
Published: (2008-12-01)

Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor‐positive breast cancer: A multicenter, open‐label, phase II study
by: Nobuaki Sato, et al.
Published: (2019-09-01)

Triggering of Suicidal Erythrocyte Death by Exemestane
by: Abdulla Al Mamun Bhuyan, et al.
Published: (2017-05-01)

Subepithelial Corneal Deposits Associated with Exemestane
by: Annahita Amireskandari, et al.
Published: (2020-01-01)

Long-term efficacy and safety of exemestane in the treatment of breast cancer
by: Walker GA, et al.
Published: (2013-03-01)

Clinical utility of exemestane in the treatment of breast cancer 
by: Zucchini G, et al.
Published: (2015-05-01)

Methylome Variation Predicts Exemestane Resistance in Advanced ER Breast Cancer
by: Xiao-ran Liu PhD, et al.
Published: (2020-03-01)

Methotrexate-Lactoferrin Targeted Exemestane Cubosomes for Synergistic Breast Cancer Therapy
by: Bekhit, A.A, et al.
Published: (2022)

Radiolabelled monoclonal antibodies for tumour immunoscintigraphy and biodistribution studies
by: Kalofonos, Haralabos
Published: (1990)

PIOS (Patras Immunotherapy Score) Score Is Associated with Best Overall Response, Progression-Free Survival, and Post-Immunotherapy Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) Treated with Anti-Program Cell Death-1 (PD-1) Inhibitors
by: Foteinos-Ioannis Dimitrakopoulos, et al.
Published: (2020-05-01)

Aromatase inhibitors in breast cancer: Signaling pathways involved in exemestane-acquired resistance
by: Tiago André Sousa Vieira Augusto
Published: (2019)

Determination of Exemestane in bulk and pharmaceutical dosage form by HPTLC
by: Maya B. Mane, et al.
Published: (2014-09-01)

Characterization and Pharmacogenetics of Hepatic Phase I Exemestane Metabolism
by: Peterson, Amity
Published: (2017)

Expression of ERα, ERβ and Co-Regulator PELP1/MNAR in Colorectal Cancer: Prognostic Significance and Clinicopathologic Correlations
by: Petros D. Grivas, et al.
Published: (2009-01-01)

Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus
by: Claudia Omarini, et al.
Published: (2018-01-01)

Analytical Method Development and Validation of Exemestane Tablet by UV Spectrophotometry
by: S. Angalaparameswari, et al.
Published: (2012-01-01)

Differentially Methylated Ultra-Conserved Regions Uc160 and Uc283 in Adenomas and Adenocarcinomas Are Associated with Overall Survival of Colorectal Cancer Patients
by: Anastasia E. Kottorou, et al.
Published: (2020-04-01)

The Survivin −31 Snp in Human Colorectal Cancer Correlates with Survivin Splice Variant Expression and Improved Overall Survival
by: Anna G. Antonacopoulou, et al.
Published: (2010-01-01)

Development and evaluation of exemestane-loaded lyotropic liquid crystalline gel formulations
by: Muhammad Nuh Musa, et al.
Published: (2017-09-01)

Genetic Variations of CD40 and LTβR Genes Are Associated With Increased Susceptibility and Clinical Outcome of Non-Small-Cell Carcinoma Patients
by: Foteinos-Ioannis D. Dimitrakopoulos, et al.
Published: (2021-09-01)

Antiproliferative Effects of a Series of Pyrazolines on Lung Cancer
by: Belgin Sever, et al.
Published: (2018-12-01)

Everolimus Plus Exemestane for the Treatment of Advanced Breast Cancer: A Review of Subanalyses from BOLERO-2
by: Gabriel N. Hortobagyi
Published: (2015-03-01)

Antiproliferative activity of Origanum compactum extract on lung cancer and hepatoma cells
by: Wahid Chaouki, et al.
Published: (2015-08-01)

TGF-β Repressors SnoN and Ski Are Implicated in Human Colorectal Carcinogenesis
by: Vasiliki Bravou, et al.
Published: (2009-01-01)

Exceptional response to nivolumab of a heavily pre-treated patient with metastatic renal-cell cancer: from a case report to molecular investigation and future perspectives
by: Foteinos-Ioannis D. Dimitrakopoulos, et al.
Published: (2020-08-01)

Correction to: Identification of novel human RANK isoforms generated through alternative splicing. Implications in breast cancer cell survival and migration
by: Anastasios D. Papanastasiou, et al.
Published: (2018-06-01)

Antiproliferative Effect of Aminoethyl-Chitooligosaccharide on Human Lung A549 Cancer Cells
by: Dai Hung Ngo, et al.
Published: (2019-05-01)

Antiproliferative Activity of Cyanophora paradoxa Pigments in Melanoma, Breast and Lung Cancer Cells
by: Laurent Picot, et al.
Published: (2013-11-01)

Crystal engineering of exemestane to obtain a co-crystal with enhanced urease inhibition activity
by: Syeda Saima Fatima, et al.
Published: (2020-01-01)

Pharmacogenetics in Model-Based Optimization of Bevacizumab Therapy for Metastatic Colorectal Cancer
by: Apostolos Papachristos, et al.
Published: (2020-05-01)

Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers
by: Hande Beklen, et al.
Published: (2021-09-01)